Vitamins
How to Test Your B12 Level: Methods, Ranges, and What Results Mean
Most people testing their B12 level never get the full picture. Standard serum B12 can look normal while functional deficiency quietly drives fatigue, nerve damage, and cognitive decline. Understanding which tests to order — and how to read them — changes everything.

How to Test Your B12 Level: Methods, Ranges, and What Results Mean
Yes, you can test your B12 level with a standard serum blood draw — but serum B12 alone is an unreliable marker. It measures total circulating B12, including inactive analogs that inflate the number without contributing to cellular function. The more accurate approach combines serum B12 with methylmalonic acid (MMA) and homocysteine to confirm whether B12 is actually working at the tissue level. The exception: vegans and people on metformin should prioritize this functional testing from the start, not after symptoms develop.
---
Why Serum B12 Alone Misses the Point
Serum B12 is the most commonly ordered test, and it's a reasonable first screen. The reference range used in most U.S. labs runs from roughly 200 to 900 pg/mL, though some labs set the lower cutoff at 160 or 180 pg/mL. The problem is that serum B12 captures both active and inactive forms. Up to 20% of circulating B12 is bound to haptocorrin — a carrier protein that transports biologically unavailable analogs (Clarke et al., New England Journal of Medicine 2003; PMID: 12529459). That means someone reading 300 pg/mL could still be functionally deficient.
Subclinical B12 deficiency is estimated to affect 6% of adults under 60 and nearly 20% of those over 60 in Western populations (Allen, American Journal of Clinical Nutrition 2009; PMID: 19116323). The majority of these individuals would not be flagged by serum B12 alone — which is precisely why functional markers matter.
---
The Four Tests That Give You a Complete B12 Picture
1. Serum B12 (Cobalamin)
This is your starting point. Order it fasted. Values above 400 pg/mL are generally considered adequate; the range from 200–400 pg/mL is a gray zone where functional testing becomes essential. Values above 900 pg/mL warrant follow-up — elevated B12 can indicate liver disease, myeloproliferative disorders, or supplement over-supplementation. For a detailed walkthrough of what high readings mean, see what a high B12 level means or what a low B12 level means for your health.
2. Methylmalonic Acid (MMA)
MMA is the most sensitive and specific functional marker of B12 status currently available. When B12 is insufficient, the enzyme methylmalonyl-CoA mutase — which requires B12 as a cofactor — cannot convert methylmalonyl-CoA into succinyl-CoA. MMA accumulates as a result. Elevated serum MMA (above 0.26 µmol/L) in the presence of borderline serum B12 confirms functional deficiency (Stabler, New England Journal of Medicine 2013; PMID: 23301733). MMA can also be measured in urine; urinary MMA above 3.6 µg/mg creatinine similarly indicates inadequate cellular B12.
3. Homocysteine
Homocysteine rises when both B12 and folate are insufficient, because both vitamins are needed for the remethylation of homocysteine to methionine. Normal fasting homocysteine sits below 10 µmol/L; levels above 15 µmol/L are classified as hyperhomocysteinemia, a known cardiovascular and cognitive risk factor. Homocysteine is less specific than MMA for B12 alone — folate deficiency raises it too — so it's best interpreted alongside MMA and serum folate. For guidance on testing folate alongside B12, how to test your folate level covers methods and ranges in detail.
4. Holotranscobalamin (Active B12)
Holotranscobalamin (holoTC) measures only the active fraction of serum B12 — the portion bound to transcobalamin II, which cells can actually absorb and use. It's the earliest marker to decline when B12 intake drops. Reference ranges vary by lab, but values below 35 pmol/L are generally considered low, and below 20 pmol/L is flagged as deficient. HoloTC is not universally available through standard U.S. labs, but it is offered through specialty panels and functional medicine providers.
| Test | What It Measures | Optimal Range | Limitation |
|---|---|---|---|
| Serum B12 | Total circulating cobalamin | > 400 pg/mL | Includes inactive analogs |
| Methylmalonic Acid (MMA) | Functional B12 at cellular level | < 0.26 µmol/L (serum) | Rises in kidney disease regardless |
| Homocysteine | Remethylation capacity (B12 + folate) | < 10 µmol/L | Non-specific — folate also drives it |
| Holotranscobalamin | Active B12 fraction only | > 35 pmol/L | Not available at all standard labs |
---
Who Should Test — and How Often
Certain populations carry substantially elevated deficiency risk and should test B12 proactively, not reactively:
- Vegans and vegetarians: B12 exists almost exclusively in animal-sourced foods. Without supplementation, deficiency is nearly universal over time.
- Adults over 50: Gastric acid production declines with age, reducing absorption of food-bound B12. Crystalline B12 from supplements and fortified foods bypasses this bottleneck.
- Metformin users: Long-term metformin therapy reduces B12 absorption via interference with ileal calcium-dependent uptake. A 2010 randomized trial of 390 type 2 diabetics found that metformin significantly reduced B12 levels compared to placebo over 4.3 years (de Jager et al., BMJ 2010; PMID: 20488910).
- People with gastrointestinal conditions: Crohn's disease, celiac disease, gastric bypass, and low stomach acid (atrophic gastritis) all impair B12 absorption.
- Individuals with PCOS: Metformin is frequently prescribed in PCOS management, making regular monitoring important. For context on B12 norms in this population, what is a normal B12 level in PCOS goes deeper.
- Women in perimenopause and postpartum: Hormonal shifts and nutritional demands from pregnancy affect B12 status. See B12 in perimenopause for reference ranges specific to that life stage.
For healthy adults with no risk factors, annual testing alongside routine bloodwork is reasonable. For the groups above, testing every 6–12 months is prudent — especially if supplementing, since supplementation can normalize serum B12 while MMA remains elevated.
---
Understanding Optimal Versus Reference Ranges
Lab reference ranges are built from population distribution, not from outcome data. This distinction matters enormously for B12. The conventional lower cutoff of 200 pg/mL means roughly 2.5% of a population will be flagged — but research consistently shows that neurological and cognitive symptoms can appear at levels well above that threshold.
A 2013 review in the New England Journal of Medicine found that neuropsychiatric symptoms of B12 deficiency, including subacute combined degeneration of the spinal cord, can appear even when serum B12 falls in the low-normal range (Stabler 2013; PMID: 23301733). Many functional medicine and integrative practitioners target serum B12 above 500–600 pg/mL and maintain MMA below 0.20 µmol/L as a tighter functional goal.
For life stages with elevated requirements — pregnancy, postpartum, perimenopause — these targets may shift further. Reference ranges specific to those contexts are available in dedicated guides on normal B12 levels postpartum and B12 in menopause.
---
Secondary Markers Worth Running Alongside B12
B12 doesn't operate in isolation. If you're doing a thorough nutritional panel, several other biomarkers contextualize the picture:
Folate (RBC and serum): Because folate and B12 share the methylation cycle, deficiency in one can mask the other on certain tests. RBC folate reflects longer-term status than serum folate.
Complete Blood Count (CBC): Macrocytic anemia — large, immature red blood cells — is a classic downstream consequence of B12 deficiency. It's a late-stage finding, but a useful confirmatory data point.
Complete Metabolic Panel: Elevated creatinine can artificially raise MMA independent of B12 status, so kidney function is an important covariate when interpreting MMA results.
Thyroid panel: Hypothyroidism and autoimmune thyroid disease are associated with pernicious anemia (the autoimmune cause of B12 malabsorption), so testing these together is clinically efficient.
If your ordering a broader cardiovascular or nutrient panel, it's also worth considering whether your omega-3 index has been measured — both B12 and omega-3 status contribute independently to cognitive and cardiovascular outcomes, and both are routinely suboptimal in plant-forward diets.
---
How Ones Addresses B12 and Nutrient Deficiency
Ones takes a data-driven approach to B12 and related nutrient gaps. When a user's lab results — including serum B12, MMA, homocysteine, or CBC findings — are uploaded to the platform, the AI health practitioner interprets them alongside wearable data and health history to determine what's actually driving the gap. This isn't a one-size multi: it's a targeted formula calibrated to what your bloodwork shows.
For confirmed B12 deficiency or borderline status, Ones includes methylcobalamin — the active, neurologically preferred form of B12 — rather than cheaper cyanocobalamin that requires additional conversion steps in the body. For individuals with elevated homocysteine driven by combined B12 and folate insufficiency, Ones incorporates methylfolate (5-MTHF), the bioavailable form that bypasses MTHFR polymorphisms affecting conversion.
Beyond B12 specifically, the platform recognizes that nutritional gaps rarely appear alone. If your panel shows suboptimal B12 alongside low omega-3 index — a combination associated with accelerated cognitive aging — Ones can include clinically dosed EPA/DHA in the same daily formula. The omega-3 index as a cardiovascular risk marker is one of the clearest examples of how a single nutrient biomarker can reshape a supplement strategy when properly measured.
Formulas are calibrated to 6 or 9 capsules daily depending on the user's findings — not chosen by the user, but determined by what the AI identifies as clinically indicated based on the full data picture.
---
A Practical Step-by-Step Testing Protocol
- Order a fasted blood draw including serum B12, MMA (serum or urine), homocysteine, folate (RBC and serum), and CBC. If available, add holotranscobalamin.
- Review serum B12 against an optimal threshold — not just the lab's reference range. Flag anything below 400 pg/mL for functional follow-up.
- Check MMA and homocysteine to determine whether low serum B12 reflects genuine cellular insufficiency or is an isolated finding.
- Identify your personal risk factors: Are you vegan? Taking metformin or a PPI? Over 50? These push the testing frequency and the optimal threshold higher.
- Retest after 90 days of supplementation to verify that serum B12 and MMA are responding. Serum B12 rises faster; MMA normalizes more slowly and is the more reliable endpoint marker.
- Contextualize with thyroid and metabolic markers if pernicious anemia or malabsorption is suspected — intrinsic factor antibodies and anti-parietal cell antibodies confirm autoimmune causation.
---
Key Takeaways
- Serum B12 is a necessary but insufficient screen — MMA and homocysteine are needed to confirm functional deficiency at the cellular level.
- The conventional lab lower limit (~200 pg/mL) is too permissive; neurological symptoms can appear at levels that fall within the reference range. Target above 400–500 pg/mL with MMA below 0.26 µmol/L.
- Vegans, adults over 50, metformin users, and people with GI conditions should test proactively every 6–12 months.
- Holotranscobalamin (active B12) is the earliest marker to decline — worth requesting if available.
- B12 testing should be paired with folate, homocysteine, CBC, and kidney function markers to interpret results accurately.
- When deficiency is confirmed, choose methylcobalamin over cyanocobalamin for neurological efficacy, and address co-deficiencies (folate, omega-3) in the same protocol.
---
This article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your supplement or testing protocol.